Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Healthcare Company (ACHC) Return on Sales (2016 - 2025)

Historic Return on Sales for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to 0.04%.

  • Acadia Healthcare Company's Return on Sales fell 400.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.08% for FY2024, which is 1200.0% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported Return on Sales of 0.04% as of Q3 2025, which was down 400.0% from 0.04% recorded in Q2 2025.
  • Acadia Healthcare Company's Return on Sales' 5-year high stood at 0.13% during Q2 2022, with a 5-year trough of 0.38% in Q2 2021.
  • Over the past 5 years, Acadia Healthcare Company's median Return on Sales value was 0.04% (recorded in 2025), while the average stood at 0.0%.
  • Within the past 5 years, the most significant YoY rise in Acadia Healthcare Company's Return on Sales was 15300bps (2021), while the steepest drop was -4100bps (2021).
  • Over the past 5 years, Acadia Healthcare Company's Return on Sales (Quarter) stood at 0.01% in 2021, then soared by 1812bps to 0.09% in 2022, then crashed by -149bps to 0.05% in 2023, then skyrocketed by 194bps to 0.04% in 2024, then rose by 4bps to 0.04% in 2025.
  • Its Return on Sales stands at 0.04% for Q3 2025, versus 0.04% for Q2 2025 and 0.01% for Q1 2025.